REACH Compliance

What Is REACH Compliance?

REACH stands for Registration, Evaluation, Authorization, and Restriction of Chemicals—a comprehensive EU chemicals regulation (EC No 1907/2006) that came into force on 1 June 2007. It governs how chemical substances are manufactured, imported, and used in the EU, and seeks to protect human health and the environment.

Who Must Comply with REACH in Pharma?

REACH applies to companies in the pharmaceutical sector that manufacture, import, or handle chemical substances or mixtures in quantities exceeding 1 tonne per year. This includes APIs, excipients, solvents, and other intermediates used in medicine production. Both manufacturers and importers must register these substances with the European Chemicals Agency (ECHA).

What are the Core Pillars of REACH?

REACH is built on four regulatory pillars:

1. Registration: Required for substances produced or imported in volumes above 1 tonne per year.
2. Evaluation: ECHA reviews dossiers for compliance; substances may face further regulatory scrutiny.
3. Authorization: Substances of Very High Concern (SVHCs) require special approval for continued use.
4. Restriction: Use of certain hazardous chemicals may be banned or limited via REACH Annex XVIII.

The burden of proof lies with industry—to assess risk, demonstrate safety, and ensure responsible use.

How Should Companies Maintain Ongoing REACH Compliance?

• Register high-volume substances through ECHA.
• Keep dossiers current: Administrative updates must be addressed within 3 months, complex updates within 6–12 months.
• Monitor SVHC listing changes and comply with new requirements if thresholds are exceeded.

What are Real-World Scenarios of REACH Compliance?

• API Importers: Submit complete registration dossiers for APIs entering the EU for formulation and manufacturing.
• Excipient Suppliers: Register or ensure coverage for regulated excipient usage when importing or distributing in bulk.
• Use of SVHC Intermediates: Substances flagged as SVHC must be authorized, or suitable non-SVHC alternatives pursued.
• Downstream Notification: If an article contains >0.1% SVHC, companies must notify ECHA and communicate safe-use information.

Related Terms and Internal Linking

• SVHC (Substance of Very High Concern)
• Chemical Safety Report (CSR)
• Regulatory Dossiers: DMF, CEP, CTD
• GMP and API Sourcing

REACH Compliance FAQs 

Does REACH compliance apply outside the EU?

REACH applies to any company exporting substances into the EU, meaning non-EU manufacturers must appoint an Only Representative in the EU to handle registration obligations.

What is the difference between REACH and CLP?

REACH regulates chemical use and registration, while CLP (Classification, Labelling and Packaging) governs hazard communication via labels and safety data sheets under EU law.

How does REACH impact pharmaceutical excipients?

Under REACH, pharma excipients are treated as chemical substances, requiring registration, hazard data, and compliance with exposure limits if imported or manufactured above 1 tonne/year.

What penalties exist for REACH non-compliance?

Penalties vary by country but may include substantial fines, product recalls, or market bans, as non-compliance violates EU chemical safety law and disrupts regulatory approvals.

Can REACH dossiers support global regulatory filings?

Yes. REACH dossiers often overlap with international submissions like US TSCA or China MEE, allowing companies to streamline compliance while meeting EU requirements first.